Puma Biotechnology, Inc. (NYSE: PBYI) is adding to yesterday's 2% gains which was related to sector takeover speculation following Roche's ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE